Upcoming studies associated with the mechanism of action will be conducted on PBMC, spleen cells and CD4 T cells harvested from S. mansoni-infected mice treated with PZQ at 18 mg/kg/day for 28 days to evaluate the Th1, Th2, and Th17 responses at different stages of the infection. This evidence concerns the gene CD4 and infection.